Cita APA

Koralkova, P., Belickova, M., Kundrat, D., Dostalova Merkerova, M., Krejcik, Z., Szikszai, K., . . . Divoky, V. (2021). Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34(+) Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients. Cancers (Basel).

Chicago Style Citation

Koralkova, Pavla, et al. "Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated With Quiescence of CD34(+) Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients." Cancers (Basel) 2021.

Cita MLA

Koralkova, Pavla, et al. "Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated With Quiescence of CD34(+) Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients." Cancers (Basel) 2021.